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Purpose: Recently, several clinicians have reported the advantages of simplicity 
and cosmetic satisfaction of absorbable mesh insertion. However, there is insuffi-
cient evidence regardint its long-term outcomes. We have investigated the surgical 
complications and postoperative examination from the oncologic viewpoint. Mate-
rials and Methods: From February 2008 to March 2009, 34 breast cancer patients 
underwent curative surgery with absorbable mesh insertion in Samsung Medical 
Center. Patient characteristics and follow up results including complications, clini-
cal and radiological findings were retrospectively investigated. Results: The mean 
age of the study population was 50.1±8.9 years old (range 31-82) with a mean tumor 
size of 3±1.8 cm (range 0.8-10.5), and the excised breast tissue showed a mean vol-
ume of 156.1±99.8 mL (range 27-550). Over the median follow-up period of 18±4.6 
months (range 3-25), mesh associated complications, including severe pain or dis-
comfort, edema, and recurrent fluid collection, occurred in nine patients (26.5%). In 
three cases (8.8%), recurrent mastitis resulted in mesh removal or surgical interven-
tion. In the postoperative radiologic survey, the most common finding was fluid col-
lection, which occurred in five patients (16.1%), including one case with organizing 
hematoma. Fat necrosis and microcalcifications were found in three patients (9.7%). 
Conclusion: Absorbable mesh insertion has been established as a technically feasi-
ble, time-saving procedure after breast excision. However, the follow-up results 
showed some noticeable side effects and the oncologic safety of the procedure is 
unconfirmed. Therefore, we suggest that mesh insertion should be considered only 
in select cases and should be followed-up carefully.
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INTRODUCTION
 
Absorbable surgical mesh insertion has recently been introduced for volume re-
placement after partial mastectomy. The idea is that the absorbable polyglycolic 
acid mesh may enable the breast to maintain its shape after excision of the dis-
eased tissue by forming reactive fluid with capsulation via creation of peri-fibrosis Min Young Koo, et al.
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were performed in a routine manner. After confirmation of 
complete excision of the tumor by intraoperative frozen bi-
opsy and meticulous bleeding control, the breast is irrigated 
with warm distilled water 2 to 3 times, on equal terms with 
general breast surgery. The absorbable mesh is designed 
and manipulated with absorbable sutures into the breast as 
previously reported. To prevent adhesion between mesh 
and the tissue, the mesh is sealed up with oxidized regener-
ated cellulose (Interceed®, Ethicon, Somerville, USA). The 
sector-shaped folded mesh, wrapped in the cellulose com-
plex, is put into the defect of the breast and secured with a 
few stitches of absorbable suture to prevent rotation. 
A drain is not inserted, because the absorption of the mesh 
via hydrolysis, reactive fluid formation, granulation reaction 
interferes with mechanical drainage. Intravenous (IV) anti-
biotics are injected within one hour prior to the operation. 
Postoperatively, after two or three days of IV antibiotics, 
oral antibiotics are prescribed for less than five days. 
Post-operative survey included a medical record review, 
patient interview, and investigation of radiologic findings. 
Mammography and ultrasound were used for the postoper-
ative radiologic survey. 
RESULTS
 
The mean age was 50.1 years old (range 31-82) with a mean 
tumor size of 3±1.8 cm (range 0.8-10.5), and the excised 
breast tissue showed a mean volume of 156.1±99.8 mL 
(range 27-550). The upper outer quadrant was the most 
common tumor site (Table 1). Invasive ductal carcinoma 
was found in 25 patients (73.5%), followed by ductal carci-
noma in site in 6 patients (17.7%), including 2 cases of in-
vasive lobular carcinoma and one case of invasive tubular 
carcinoma. Most of the patients were early breast cancer 
patients but three (8.8%) were stage III. Consequent adju-
vant hormonal or chemotherapy was undertaken in the 
standard manner according to the patient’s disease stage. 
All but two patients refused to have radiation therapy.
During the median follow-up period of 18±4.6 months 
(range 3-25), mesh associated complications, including se-
vere pain, discomfort and edema, occurred in nine patients 
(29.4%). Among these nine patients, mesh removal was in-
evitable in three cases (8.8%) of serious complications, one 
because of recurrent mastitis and two because of wound de-
hiscence. In the other six cases, there were symptoms of 
persistent pain, skin contraction, skin color change, and re-
and formation of granulation tissue at the peripheral area of 
the mesh, with gradual absorption of foreign material.1,2 In 
general, oxidized regenerated cellulose is also used to pre-
vent adhesion between the skin and the polyglycolic acid 
mesh.1 According to the previous reports, the absorbable 
mesh insertion is a simple, time-sparing technique.1 
In breast cancer surgery, breast conservation has become 
the standard therapy, with better patient satisfaction and com-
parable long-term outcomes than total mastectomy.3 Still, 
surgeons and patients have continuously tried to achieve the 
oncologic goals of complete tumor excision with enough 
margins as well as good aesthetic outcomes with the re-
maining breast.4 Especially for Asian women with small 
dense breasts, volume replacement after partial excision has 
been one of the major concerns and one of the great obsta-
cles for partial mastectomy at the same time. Preliminary 
use of mesh suggested it as an ideal alternative for volume 
replacement. 
Since 2005, when it was first introduced, many clinicians 
have reported positive cosmetic results with a comparably 
lower rate of complications at a minimal cost.5 Also, some 
studies with questionnaires have demonstrated comparable 
cosmetic satisfaction of patients with breast malignancies 
or benign breast diseases.1,6,7 However, these results have 
been limited to short-term outcomes of less than one year,7,8 
and long-term outcomes have not been fully elucidated from 
the viewpoint of post-operative surveillances and oncologic 
safety. The aim of this study is to review the immediate and 
the long-term post-operative outcomes over a year after 
mesh insertion.
MATERIALS AND METHODS
　　　
From February 2008 to March 2009, 34 breast cancer pa-
tients received partial mastectomy with axillary procedure, 
such as sentinel lymph node biopsy or axillary lymph node 
dissection, followed by insertion of absorbable mesh (Poly-
glactic 910, Vicryl®) at Samsung Medical Center, Sung-
kyunkwan University School of Medicine. The electronic 
medical records of these patients were retrospectively re-
viewed. Patient characteristics and follow-up results includ-
ing complications, aesthetic outcomes, and clinical and ra-
diological findings were investigated.
The oncologic surgical procedure including partial mas-
tectomy and axillary lymph node excision with either senti-
nel lymph node biopsy or axillary lymph node dissection Absorbable Mesh Insertion in Partial Mastectomy
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Ultrasound examination also showed problematic results. 
There were not only simple well-capsulated fluid collec-
tions or typical ovoid benign-looking mass formations, but 
also irregularly demarcated mass formation or extracavity 
iso- to hyper-echoic lesion, which may significantly inter-
fere with the discrimination of local recurrences (Figs. 2A 
and B). The most common findings were persistent fluid 
collection in six patients (19.4%), including one case with 
organizing hematoma. Fat necrosis was found in four pa-
tients (12.9%). A benign-looking mass at the operation site 
was present in one other case (3.2%).
DISCUSSION
   
Oncoplastic surgery is defined as combination of excision 
of a tumor, with appropriate margin including lumpectomy 
or mastectomy, and immediate reconstruction of the breast.9 
This technique has become rapidly more accepted through-
out Western countries, enabling the achievement of onco-
logically safe margin and satisfactory cosmetic results.10 
Recently, comparable results have been reported for local 
recurrence and survival outcome.11-13 Absorbable surgical 
mesh is the latest method in oncoplastic surgery. Since 2005, 
when the absorbable mesh was first introduced in Korea, a 
peated seroma formation. 
Two patients (5.9%) were lost during follow-up. One of 
these patients complained that she had persistent pain, which 
slowly improved with conservative management. Because 
she argued that she had general weakness due to her age 
(84), hospital visits were discontinued. The other patient de-
veloped severe mastitis two days after the first cycle of ad-
juvant chemotherapy, so the mesh was removed after 45 
days of initial operation. This patient was referred to a local 
hospital due to accessibility problems from her residence to 
the hospital and follow up radiologic exam or clinical course 
was not obtained after mesh removal. These two patients 
were excluded from the imaging surveillance analysis. 
During postoperative surveillance with mammography, 
heterogeneous changes were often found, such as paren-
chymal changes, ranging from simple skin dimpling or post 
operative parenchymal deformity, to speculated or irregular 
formation of mass densities (Fig. 1A). Five patients (14.7%) 
presented with findings with significant alert. Microcalcifi-
cations at the operation site suggesting fat necrosis were 
noted in three cases (8.8%), and an increase in the number 
of microcalcifications was found in two patients (6.9%) (Fig. 
1B). The other two patients (6.9%) presented with mass-like 
densities (fluid collection), and reticular density (foreign 
body shadow). 
Table 1. Clinical Characteristics of Patient with Absorbable 
Mesh Insertion
Characteristics Result
Age (median, range, yrs) 50 (range 31-82)
BMI (mean, kg/m
2) 23.8±2.4 (range 20-28.8)
Location
Upper 19 (55.9%)
Mid   7 (20.6%)
Lower   8 (23.5%)
Inner 11 (32.4%)
Center   7 (20.6%)
Outer 16 (47.4%)
Volume of tissue 156±99.8 mL (range 27-550)
Tumor size 3±1.8 cm (range 0.8-10.5)
Histology
DCIS   6 (17.7%)
IDC 25 (73.5%)
Others*   3 (8.8%)
Stage
0   6 (17.6%)
I 13 (38.2%)
II 12 (35.3%)
III   3 (8.8%)
Chemotherapy Yes 20 (58.8%)
Radiation therapy Yes 32 (94%)
BMI, body mass index; DCIS, ductal carcinoma in site; IDC, invasive ductal 
carcinoma. 
*invasive lobular carcinoma 2 cases, invasive tubular carcinoma 1 case.
Fig. 1. Mammographic findings after mesh insertion (A) various shapes of 
mass densities (arrow) were found, ranging from mild skin dimpling to het-
erogeneous mass densities. (B) Microcalcifications suggesting fat necro-
sis (circle) were found at the operation site. 
A
BMin Young Koo, et al.
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problems or in higher risk patients such as diabetics or the 
elderly, though the specific age criteria has not been clearly 
stated.5 This study, in which the mean body mass index of 
23.8 kg/m2, included no extraordinarily obese patients. 
Also, one patient was a tobacco user, but the patients did 
not suffer from an adverse outcome. Unfortunately, due to 
the small sample size of patients with complications, de-
tailed analysis on development or preventive factors for 
complications were not available. 
Although a statistical relationship was not established, 
adjuvant chemotherapy tended to affect the wound prob-
lem. Moreover, resolution of infectious complications re-
quired removal of the mesh. Some surgeons had recom-
mended the use of prophylactic antibiotics, but until now, 
the requirement or the amount of necessary antibiotics has 
not been established. Also, radiation-induced skin reactions, 
such as erythema and hyperpigmentation, have been report-
ed.8 After permanent implant insertion, the occurrence of 
complications such as infection, hematoma, and extrusion 
of the implant increase with more extensive history of irra-
national survey showed that more than two third of breast 
surgeons had experience with the mesh insertion technique.5 
The simplicity of the time-preserving technique that is easily 
applicable has been reported to have significant advantages 
for surgeons along with a relatively low cost and acceptable 
cosmetic outcomes.8 However, until now there has been in-
sufficient evidence concerning the results of the mesh inser-
tion. Previous studies were limited to the occasional report of 
observational analysis of immediate postoperative outcomes. 
The majority of the clinicians agree that the mesh inser-
tion involves the risk of wound complications or relatively 
prolonged use of antibiotics. In the national survey, the in-
fection rate has been reported as up to 3.8%.5 On the con-
trary, another report with a longer follow-up period of 22 
months after the operation showed a 14.3% higher compli-
cation rate and a relatively smaller number of patients.6 Our 
results revealed slightly higher incidence of wound compli-
cations compared to national survey. Up to now, infection 
has been the most commonly encountered problem, and the 
mesh is contraindicated in patients with possible wound 
Fig. 2. Ultrasound findings after mesh insertion (A) Well-circumscribed cyst and ovoid shape nodules suggest granulomatous reaction to 
foreign body. (B) Ill-defined, irregular margined mass or extra-cavity lesions (arrows) may mimic local recurrence.  
A
B
Table 2. Local Complications of Absorbable Mesh Insertion
Degree Type No. of patients Duration
Tolerable
Persistent pain 2 18, 23 months
Skin contraction 2 23, 13 months
Skin color change 1 20 months
Repeated seroma formation   1* 23 months
Serious
Mastitis  1
†
Wound dehiscence    2
‡,§
No., number.
*up to 23 months after mesh insertion.
†symptom onset at 45 days after mesh insertion after chemotherapy.
‡symptom onset at 47 days after mesh insertion after chemotherapy, underlying DM.
§initial at POD #17, #30 removal at POD #40.Absorbable Mesh Insertion in Partial Mastectomy
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sue; however, four patients were found to have a suspicious 
ill-defined mass that caused significant concern of local re-
currence. Fat necrosis can be easily confused with breast le-
sions, which require differential diagnosis from malignancy 
in both clinical and radiological aspects. Fat necrosis may 
contain calcifications or fibrosis, which can appear as a spec-
ulated mass and may have a scirrhous feel upon examina-
tion. Potential fat necrosis or presentation of atypical calci-
fications should undergo core needle or excisional biopsy 
for pathologic confirmation.19-22 
When planning treatment for breast cancer patients, long-
term survival, local recurrence, psychological adjustment, 
functional competence, sexual adaptation and cosmetic out-
come are all essential elements.3 A few studies had investi-
gated the aesthetic outcome in mesh insertion patients and 
reported improved cosmetic satisfaction, psychological ad-
vantage, contour maintenance based on the questionnaire 
survey.6 77.6% of breast surgeons reported improved cos-
metic outcomes after surgery, and 42.9% of surgeons re-
ported higher patients satisfaction.5 On the other hand, 25% 
surgeon reported that the postoperative cosmetic results 
worsen as time passes.5 This study focuses mainly on the 
surgical and oncologic aspects of the postoperative out-
come. From the viewpoint of cosmetically tolerable results 
with oncologic removal of breast cancer, reconstruction or 
oncoplastic surgery can be alternatives to mesh insertion. 
The inevitable adoption of invasive procedures for histo-
logic confirmation for the vague lesion during follow up 
can generate a great deal of stress in breast cancer patients. 
If we consider that volume may decrease up to 47% after 
approximately one year,15 we should deliberate a carefully 
before deciding upon insertion of absorbable mesh for breast 
cancer patients, especially for those who are candidates for 
adjuvant chemo-radiation therapy. 
In conclusion, absorbable mesh insertion has been report-
ed to be a technically feasible and time-preserving proce-
dure. However, follow-up results from an extended period 
have shown some significant considerations, such as inter-
ference in postoperative surveillance for local recurrences, 
chronic pain and wound infections. Therefore, we suggest 
that mesh insertion should be carefully considered and ad-
ministered only in select cases. In postoperative radiologic 
surveillance, clinicians should be aware of the possible in-
terference from mesh-related changes that may mimic local 
recurrence. Future investigation with long-term result is a 
prerequisite for clinical use of absorbable mesh for breast 
cancer patients.
diation.14 However, the relationship between radiation ther-
apy and wound complication after absorbable mesh inser-
tion is not clear. 
Another major issue with mesh insertion in breast cancer 
patients is postoperative surveillance. Permanent insertion 
of a foreign body may induce inflammation or local re-
sponse. Previous research on biomechanical materials us-
ing polyglactin 910, Vicryl® demonstrated a pronounced 
level of inflammation and an increased level of connective 
tissue formation at the interface.2 Histologically, perifila-
mentary inflammation occurs, resulting in chronic forma-
tion of foreign-body giant cells and lymphocytes in the pe-
riphery of the granuloma.2,15 Although the long-term changes 
have not yet been identified, the local response to the ab-
sorbable mesh may implicate future problems.  
There have been several studies that suggested that the 
absorbable mesh insertion is not related to infectious com-
plications. Góes, et al.16 reported that absorbable mesh in-
sertion in the breast did not interfere with mammographic 
postoperative surveillance in detecting minute lesions such 
as calcifications and small nodules, but showed only mini-
mal complications such as seroma and loss of areolar sensi-
tivity, without causing wound infection. They reported that 
fat necrosis and cyst formation is common. However, 
breast cancer patients were not included in this analysis and 
the author emphasized that cancer patients are not a suitable 
subject because they require future radiation therapy and 
rigid control of tumor relapse.17 There were two Korean re-
ports that investigated postoperative radiologic changes in 
the operation site after mesh insertion. According to these 
reports, the most common local finding was well-capsulat-
ed cyst formation with an iso-echoic, benign looking nod-
ule.15,18 However, these studies are limited by a small num-
ber of patients and a rather short follow-up duration. There 
were no cases with infectious complications, but over-for-
mation of fluid collection was found in one patient. Mean-
while, mammographic results or adjuvant treatments were 
not taken into account in the analysis.18
In this study, microcalcifications suggesting fat necrosis 
were found at the operation bed and the number of the mi-
crocalcifications was increased in the follow-up serial exam 
in three patients. Also, heterogeneous formations of mass 
densities were found in the mammographic surveillance in 
two patients. In the ultrasound exam, a mass-like shadow at 
the operation bed revealed various shapes of residual mate-
rials after absorption of the mesh. Similarly to previous re-
ports, seven cases showed benign-looking granulation tis-Min Young Koo, et al.
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